All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Deferiprone
Therapeutic Area: Genetic Disease Product Name: Undisclosed
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: CHIESI USA INC
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition January 13, 2020
Details:
Chiesi Group expands distribution network via acquisition for worldwide product rights.